Abstract:The issue of multi-drug-resistant tuberculosis (MDR-TB) presents a substantial challenge to global public health. Regrettably, the diagnosis of drug-resistant tuberculosis (DR-TB) frequently necessitates an extended period or more extensive laboratory resources. The swift identification of MDR-TB poses a particularly challenging endeavor. To identify the biomarkers indicative of multi-drug resistance, we conducted a screening of the GSE147689 dataset for differentially expressed genes (DEGs) and subsequently conducted a gene enrichment analysis. Our analysis identified a total of 117 DEGs, concentrated in pathways related to the immune response. Three machine learning methods, namely random forest, decision tree, and support vector machine recursive feature elimination (SVM-RFE), were implemented to identify the top 10 genes according to their feature importance scores. A4GALT and S1PR1, which were identified as common genes among the three methods, were selected as potential molecular markers for distinguishing between MDR-TB and drug-susceptible tuberculosis (DS-TB). These markers were subsequently validated using the GSE147690 dataset. The findings suggested that A4GALT exhibited area under the curve (AUC) values of 0.8571 and 0.7121 in the training and test datasets, respectively, for distinguishing between MDR-TB and DS-TB. S1PR1 demonstrated AUC values of 0.8163 and 0.5404 in the training and test datasets, respectively. When A4GALT and S1PR1 were combined, the AUC values in the training and test datasets were 0.881 and 0.7551, respectively. The relationship between hub genes and 28 immune cells infiltrating MDR-TB was investigated using single sample gene enrichment analysis (ssGSEA). The findings indicated that MDR-TB samples exhibited a higher proportion of type 1 T helper cells and a lower proportion of activated dendritic cells in contrast to DS-TB samples. A negative correlation was observed between A4GALT and type 1 T helper cells, whereas a positive correlation was found with activated dendritic cells. S1PR1 exhibited a positive correlation with type 1 T helper cells and a negative correlation with activated dendritic cells. Furthermore, our study utilized connectivity map analysis to identify nine potential medications, including verapamil, for treating MDR-TB. In conclusion, our research identified two molecular indicators for the differentiation between MDR-TB and DS-TB and identified a total of nine potential medications for MDR-TB.

MicroRNA signatures from multidrug‑resistant Mycobacterium tuberculosis

Longitudinal Molecular Epidemiological Study of Multidrug Resistant Tb and Transition to Extensively Drug Resistance in Eastern Rual China

Profiling the Mrna and Mirna in Peripheral Blood Mononuclear Cells in Subjects with Active Tuberculosis

Screening and identification of differentially expressed long non-coding RNAs in multidrug-resistant tuberculosis

The Novel Gene Mtb192 is a Candidate Marker for the Detection of Multidrug-Resistant Mycobacterium Tuberculosis Strains.

MicroRNAs As Immune Regulators and Biomarkers in Tuberculosis

Comparative Genomic Analysis of Two Clonally Related Multidrug Resistant Mycobacterium tuberculosis by Single Molecule Real Time Sequencing

Molecular Indicator for Distinguishing Multi-drug-Resistant Tuberculosis from Drug Sensitivity Tuberculosis and Potential Medications for Treatment

Comparative Mirna Expression Profiles In Individuals With Latent And Active Tuberculosis

Sputum Microbiota As a Potential Diagnostic Marker for Multidrug-Resistant Tuberculosis

Integrated Mirna and Mrna Expression Profiling to Identify Mrna Targets of Dysregulated Mirnas in Pulmonary Tuberculosis

Genomic Sequence Based Scanning for Drug Resistance-Associated Mutations and Evolutionary Analysis of Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium Tuberculosis

Bioinformatic Analysis of the Microrna-155 in Pulmonary Tuberculosis

Molecular Epidemiologic Study on Mycobacterium Tuberculosis from Drug Resistance Monitoring Sites of Guangdong Province, 2015

Differential DNA methylomes of clinical MDR, XDR and XXDR<i>Mycobacterium tuberculosis</i>isolates revealed by using single-molecule real-time sequencing

Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study

MiRNA-155 and Mirna-132 As Potential Diagnostic Biomarkers for Pulmonary Tuberculosis: A Preliminary Study.

Molecular Epidemiology and Clinical Characteristics of Drug-Resistant Mycobacterium Tuberculosis in A Tuberculosis Referral Hospital in China

The Expression of Two-Component System Response Regulator in Multidrug-Resistant Mycobacterium Tuberculosis

Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment

MiRNA expression profiles of serum exosomes derived from individuals with latent and active tuberculosis